Blocking the sEH enzyme alleviated pain [26,27], restored renal function [21,22,43], and maintained cardiac myocyte morphology and calcium cycling [54] in mouse models of diabetic neuropathy, nephropathy, and cardiomyopathy, respectively. Here, EPHX2 is linked to diabetic neuropathy.